February 17, 12:00 PM ET / 9:00 AM PT
Webinar: Details provided upon RSVP approval
Acute Respiratory Distress Syndrome is a vexing disorder with no FDA-approved therapies and a staggering unmet need. Even before the pandemic 500,000 a year people died from ARDS. Now, it is the leading cause of death among COVID-19 patients.
Aqualung CEO, Dr. Skip Garcia, CEO of Aqualung Therapeutics has one goal:
“Before I hang up my cleats, I want to get a solution into the market that can help people survive ARDS.”
Aqualung is well on their way to developing a drug platform to treat ARDS, having conducted pre-clinical studies with swine, receiving strong efficacy data. In a recent article in Endpoints News, Dr. Garcia noted that Aqualung is “making excellent progress in moving down the drug development pipeline and to ARDS Clinical Trial evaluation.”
Please join us to hear from Dr. Garcia and learn how Aqualung Therapeutics is on the verge of an important breakthrough in the treatment of Respiratory Disorders.
All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.